AKBA
Akebia Therapeutics, Inc.
$1.19
-5.20%
-0.07
Notify me if price changes either direction
Buy AKBA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
331.7M
Enterprise value
340.8M
Trailing PE
-3.5909090909091
Forward PE
-13.223158
PEG Ratio
0.035909090909091
Enterprise to EBITDA
12.494
Enterprise to revenue
1.443
Price to book MRQ
10.213008
Price to sales TTM
1.4113396
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
236.2M
EBITDA
27.3M
Diluted EPS TTM
-0.08
Total Cash (MRQ)
184.8M
Current ratio (MRQ)
1.552
Operating Cash Flow (TTM)
68.0M
AKBA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
